Crossmark

Combination therapies with thiazolidinediones are associated with a lower risk of acute exacerbations in new-onset COPD patients with advanced diabetic mellitus: a cohort-based case–control study

Crossref DOI link: https://doi.org/10.1186/s12890-021-01505-7

Published Online: 2021-04-29

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Kuan-Yuan

Wu, Sheng-Ming

Tseng, Chien-Hua

Lee, Kang-Yun

Lin, Yu-Huei

Liu, Hung-Yi

Chien, Li-Nien https://orcid.org/0000-0001-9441-552X
License Information

Text and Data Mining valid from 2021-04-29

Version of Record valid from 2021-04-29
More Information

Article History

Received: 18 August 2020

Accepted: 19 April 2021

First Online: 29 April 2021

Declarations

:

: The study protocol was approved by the Taipei Medical University-Joint Institutional Review Board (TMU-JIRB N201808075). All analyzes were performed in accordance with the relevant guidelines and regulations. Since all data were anonymously used, the TMU-IRB ethics committee approved a waiver of the requirement for informed consent. Individual patients consent was not obtained since all data used in this study were acquired retrospectively from the National Health Insurance Research Database of Taiwan.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below